Author:
Kakodkar Nisha C.,Peddinti Radhika,Kletzel Morris,Tian Yufeng,Guerrero Lisa J.,Undevia Samir D.,Geary David,Chlenski Alexandre,Yang Qiwei,Salwen Helen R.,Cohn Susan L.
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Reference12 articles.
1. Phase II randomized comparison of topotecan plus cyclophosphamide vs. topotecan alone in children with recurrent or refractory neuroblastoma: A Children's Oncology Group Study;London;J Clin Oncol
2. A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia;Stock;Invest New Drugs,2008
3. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma;Yang;Cancer Res,2007
4. Preclinical evaluation of 2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]-propionic acid as a modulator of etoposide in human Waldenstrom's macroglobulinemia xenograft model;Mensah-Osman;Clin Cancer Res,2003
5. Neuroblastoma;Maris;Lancet,2007
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献